Damian Garde
@statnews biotech reporter, inventor of CRISPR | [email protected] | Signal/WhatsApp: 202-780-9154
Last synced from Twitter 364d ago
Pharma existentialism, mainstream cyborgs, & FDA palace intrigue
What separates good drug companies from mediocre ones? Have biohackers sold out? And who's going to run the FDA?
Why in the world do we have direct-to-consumer drug advertising?
Out of the roughly 200 countries in the entire world, the U.S. is one of just two that allows drug companies to advertise on TV. Why?
MIT Media Lab founder: I would still take Jeffrey Epstein’s money today
At an internal meeting, Nicholas Negroponte shocked some people with his comments on funding from the alleged sex trafficker.
2
Damian Garde
14d
Vertex's next act: a billion-dollar bet on a cure for type 1 diabetes
The Cambridge, Mass., company announced it is buying Semma Therapeutics, a nearby firm turning stem cells into insulin factories.
Listen: Purdue, J&J, and a week of big opioid crisis news
We're devoting the entire "Readout LOUD" episode to what has been a massive week of news on the opioid crisis involving Purdue and J&J.
Vertex sinks on reports of deaths of patients taking cystic fibrosis drug
Thirty patients have died after taking a Vertex Pharmaceuticals treatment for cystic fibrosis, according to a government database.
Vertex sinks on reports of patient deaths tied to cystic fibrosis drug
Thirty patients have died after taking a Vertex Pharmaceuticals treatment for cystic fibrosis, according to a government database.
In never-before-seen video, Richard Sackler defends Purdue
The Sackler family is rarely photographed, and less frequently seen on videos. Now ProPublica has obtained video of Richard Sackler's deposition.
1
Damian Garde
here's the video of Richard Sackler talking about OxyContin that Purdue Pharma spent three years fighting to keep secret
22d
Listen: Sarepta keeps a secret & an online army mobilizes on SMA drug
In the episode, we talk about the FDA's surprise decision to reject a drug from Sarepta Therapeutics — and the company's curious way of explaining it.
Mallinckrodt to settle marketing probe, but will fight kickback case
The dispute intensifies as federal prosecutors pursue drug makers for wayward programs that provide patients with copay assistance through charities.
1
Damian Garde
among the 181 signatories is the CEO of Mallinckrodt Pharmaceuticals, which makes $1.1 billion a year from an off-patent drug whose price has increased by nearly 100,000 percent since 2000 statnews.com/pharmalot/2019… twitter.com/BizRoundtable/…
30d
How Democrats are explaining Congress’s lack of progress on drug prices
At a town hall on drug affordability this month, Rep. Chris Pappas (D-N.H.) explained, carefully, why Democrats haven't made more progress on the issue.
1
Damian Garde
what it's like when you ran on drug pricing reform and then have to explain to voters why nothing has happened
30d
Listen: The serious side of spit kits & how BiTEs leave a mark
Dorothy Pomerantz joins us this week to explain what it's like to learn devastating medical news from the website of a consumer genetic testing company.
Novartis ousted top scientists over manipulation of data for gene therapy
The pair have not been with the company since May, a disclosure that will likely amplify questions as to why Novartis delayed notifying the FDA of concerns.
Listen: Novartis and the no good, very bad week
We explain the shocking news that the Swiss pharma giant submitted falsified data to the FDA and then waited three months to inform regulators.
Novartis CEO: 'We tried to do the right things' in FDA data scandal
Vas Narasimhan also said the company was now "in the process of exiting" a small number of scientists who were "involved in these data inaccuracies.”
Novartis faces a new crisis. For CEO Vas Narasimhan, this time is different
The revelation that Novartis’s gene therapy division filed falsified data to the FDA is at the very least a blemish on its CEO. It may be a bigger crisis.
Biologist George Church apologizes for contacts with Jeffrey Epstein
The prominent scientist offered an apology for meeting with Epstein even after the financier pleaded guilty in 2008 to soliciting underage prostitution.
1
Damian Garde
George Church on how one ends up in a room with Jeffrey Epstein statnews.com/2019/08/05/cit… pic.twitter.com/q1h0xPadpl
45d
Listen: Canadian pills, corporate jets, & racists with spit kits
STAT's Nicholas Florko joins us on the podcast to explain what Trump's drug importation plan means and, perhaps more importantly, what it does not.
Why biotechs are often at the whim of things they can't control, in one chart
The gene therapy company UniQure hasn’t announced what you’d call major news in months, and yet its stock price has bounced around all summer.
ÉO Management
ÉO Management is a family office and private investment firm responsible for managing assets on behalf of the Coury family and affiliated foundation. With offices in Los Angeles, CA and Pittsburgh, PA, ÉO engages in a broad range of investments,...
1
Damian Garde
if anyone was curious about Tino Coury, son of $myl Chairman Bob Coury and singer of the jams "Diary" and "Drink My Love Away," he is now president of ÉO Management, "a family office and private investment firm"
51d